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ABSTRACT
Objectives The role of outdoor air pollution in the
incidence of chronic obstructive pulmonary disease
(COPD) remains unclear. We investigated this question
using a large, nationally representative cohort based on
primary care records linked to hospital admissions.
Methods A cohort of 812 063 patients aged 40–
89 years registered with 205 English general practices in
2002 without a COPD diagnosis was followed from
2003 to 2007. First COPD diagnoses recorded either by
a general practitioner (GP) or on admission to hospital
were identiﬁed. Annual average concentrations in 2002
for particulate matter with an aerodynamic diameter
<10 mm (PM10) and <2.5 mm (PM2.5), nitrogen dioxide
(NO2), ozone and sulfur dioxide (SO2) at 1 km
2
resolution were estimated from emission-based
dispersion models. Hazard ratios (HRs) per interquartile
range change were estimated from Cox models adjusting
for age, sex, smoking, body mass index and area-level
deprivation.
Results 16 034 participants (1.92%) received a COPD
diagnosis from their GP and 2910 participants (0.35%)
were admitted to hospital for COPD. After adjustment,
HRs for GP recorded COPD and PM10, PM2.5 and NO2
were close to unity, positive for SO2 (HR=1.07 (95% CI
1.03 to 1.11) per 2.2 mg/m3) and negative for ozone
(HR=0.94 (0.89 to 1.00) per 3 mg/m3). For admissions
HRs for PM2.5 and NO2 remained positive (HRs=1.05
(0.98 to 1.13) and 1.06 (0.98 to 1.15) per 1.9 mg/m3
and 10.7 mg/m3, respectively).
Conclusions This large population-based cohort study
found limited, inconclusive evidence for associations
between air pollution and COPD incidence. Further
work, utilising improved estimates of air pollution over
time and enhanced socioeconomic indicators, is required
to clarify the association between air pollution and
COPD incidence.
INTRODUCTION
Cohort studies have demonstrated associations
between long-term exposure to outdoor air pollu-
tion and adverse health effects.1 Such studies,
exempliﬁed by the American Cancer Society
cohort,2 3 have tended to focus on death as the
health outcome with particular emphasis on ﬁne
particles and cardiovascular disease.4 Cohort
studies of respiratory mortality have also tended to
report positive associations but individually have
lacked statistical power.5 Few studies have focused
on chronic obstructive pulmonary disease
(COPD).6 A recent report on the global impact of
PM2.5 (mass of particulates with aerodynamic
diameter <2.5 mm) on COPD was reliant on only
three studies, all from the USA and all using mor-
tality as the outcome.7
The possibility that air pollution is a risk factor for
the initiation of COPD is important given the ubiqui-
tous nature of the exposure and the substantial
burden of the disease on individuals and healthcare
services. Recent reviews of the literature have been, at
the most, only suggestive of a role of ambient air pol-
lution,6 8 and a recent multicentre cohort study
reported limited evidence of associations with air
pollution.9 Few studies have used objective measures
of disease9 or routine databases such as hospital
admissions records to identify cases.10 11
We have previously used a nationally representa-
tive cohort of adults in England to demonstrate
positive associations between annual concentrations
of air pollution and respiratory mortality including
COPD.5 In this paper, we use a subset of the same
cohort to look at the incidence of COPD over time
identiﬁed from general practitioner (GP) records
and from hospital admission records linked with the
GP record.
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What this paper adds
▸ Outdoor air pollution is a potential risk factor
for the development of chronic obstructive
pulmonary disease (COPD).
▸ Using a large, nationally representative cohort
of patients registered with 205 English general
practitioners (GP), we investigated the evidence
linking exposure to particulate matter and
gaseous pollutants to the ﬁrst diagnosis of
COPD recorded either by a GP or on admission
to hospital.
▸ We found limited evidence for associations,
although these were comparable with existing
cohort evidence based on smaller and less
nationally representative populations elsewhere.
However, given the ubiquitous nature of the
exposure and the substantial burden of COPD
on individuals and healthcare services, further
work, utilising improved estimates of air
pollution exposure for cohort participants,
longer follow-up times and more precise
disease deﬁnition, is required to clarify the role
of air pollution in the initiation of COPD.
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METHODS
The Clinical Practice Research Datalink (CPRD) is a large, vali-
dated primary care database that has been collecting anonymous
patient data from participating UK general practices since
1987.12 It includes a full longitudinal medical record for each
registered patient containing coded information on diagnoses,
prescriptions and tests carried out within the practice. The
Hospital Episode Statistics (HES) database routinely records
clinical, patient, administrative and geographical information on
all National Health Service (NHS)-funded inpatient episodes in
the UK. Subject to the practice’s approval, the CPRD patient
data are routinely linked to HES by a ‘trusted third party’ via
their NHS number, sex, date of birth and postcode and to the
Index of Multiple Deprivation (IMD), a small area measure of
deprivation used in England for allocation of resources.13
We identiﬁed 205 English practices, recording high-quality
data according to CPRD internal standards (eg, non-contiguous
follow-up, incomplete data recording),14 which had been linked
to HES data.15 From these, we identiﬁed 836 557 subjects aged
40–89 years fully registered for at least 1 year on 1/1/2003.
Subjects with COPD Read codes on their GP record prior to
2003 (n=24 494) were excluded leaving 812 063 for analysis.
First diagnoses of COPD between 2003 and 2007 were identi-
ﬁed from: (1) GP records by Read codes indicating a diagnosis
of COPD and (2) hospital admissions records by International
Classiﬁcation of Disease codes (ICD-10 Version:2010) ( J41–44)
indicating a primary diagnosis of COPD. As a sensitivity ana-
lysis, we extended the exclusion criteria to include other
markers of chronic respiratory disease recorded by the GP
including asthma and regular inhaler prescribing (all Read codes
available from authors on request). Figure 1 illustrates the
cohort selection and exclusions.
Annual mean concentrations in 2002 of particles with a median
aerodynamic diameter of <10 μm (PM10), <2.5 μm (PM2.5),
sulfur dioxide (SO2), nitrogen dioxide (NO2) and ozone (O3) for
1 km grid squares covering England were linked anonymously by
the ‘trusted third party’ from a grid centroid to the nearest residen-
tial postcode centroid for each patient. Details of the dispersion
models and the model validation including other years are pro-
vided in the online supplementary material. Brieﬂy, the models for
PM10, PM2.5, NO2 and SO2 were constructed by estimating
emissions from a number of sources (eg, road transport or power
generation) before calculating pollution concentrations using a dis-
persion model. O3 maps were constructed by interpolating data
from rural monitoring stations and adjusting for effects of altitude
and NOx emissions in urban areas.
Model validation was assessed using data from monitoring
sites in the national network and from veriﬁcation sites operated
by NETCEN (part of AEA Technology Environment) in con-
junction with local authorities and not part of the national
network.16 Model validation was good for NO2 (R
2=0.80
using the national network and 0.57 using veriﬁcation sites),
good for O3 (R
2=0.48 and 0.71), moderate for PM10 (R
2=0.29
and 0.46) and PM2.5 (R
2=0.23 and 0.71), but poor for SO2
(R2=0 and 0.39).
Potential confounders extracted from the GP records included
age, sex, smoking status (characterised as non/ex/current, with
further categories of 1–19/20–39/40+ cigarettes per day) and
body mass index (BMI) (<20, ≥20 and <25, ≥25 and <30,
≥30). The last recorded status before 1/1/2003 was used to code
the variables, except for non-smokers, who were reclassiﬁed as
ex-smokers if they had older historical codes indicating smoking.
The amount of current smoking or ex-smoking was estimated by
using the maximum cigarettes per day value and grouped accord-
ingly. A ‘missing’ category was assigned for participants with no
recorded smoking status prior to 2003. Individual measures of
socioeconomic status (SES) were not available to us and we there-
fore assessed SES using 2007 IMD deciles, which are available
for a small area comprising approximately 1500 people, modiﬁed
to remove the air quality subdomain.15 Incidence rates of COPD,
calculated from GP and hospital records separately, were com-
pared across all confounders adjusted for age and sex (Stata V.12;
StataCorp LP, College Station, Texas, USA).
We used Cox proportional hazards models (SAS V.9.1.3; SAS
Institute, Inc, Cary, North Carolina, USA) to investigate associa-
tions between pollution concentrations in 2002 and incidence of
COPD during 2003–2007. We adjusted cumulatively for (1) age
and sex; (2) smoking and BMI and (3) IMD. In a sensitivity ana-
lysis, we assessed the impact on hazard ratios (HRs) after adjust-
ment, in turn, for selected individual components of deprivation
(income, employment and education). To account for clustering
by practice, the modiﬁed sandwich estimate of variance was used
to produce robust SEs. We further assessed the effect of clustering
by ﬁtting a random effect for practice using a shared frailty
model in Stata. Two-pollutant models were considered only
when the correlation coefﬁcient between pollutants was below
0.5. We also carried out stratiﬁed analyses to assess effect modiﬁ-
cation by the covariates. To allow comparison across pollutants,
HRs were quantiﬁed for an interquartile range (IQR) change in
each pollutant. We also present the main estimates per 10 mg/m3
to enable comparison with results of other studies.
RESULTS
Postcode linkage to all pollutants was successful in 99% of
patients (table 1). IQR values were lowest for PM2.5 (1.9 mg/m
3)
and highest for NO2 (10.7 mg/m
3). There was signiﬁcant vari-
ation in modelled pollution concentrations by practice region
and IMD (p<0.001). The highest concentrations of particles
and NO2 were observed in London, whereas the highest con-
centrations of SO2 and O3 occurred in the north and south,
respectively. Areas with a lower SES were associated with higher
concentrations for all pollutants except O3. Annual concentra-
tions of PM10 and PM2.5 were strongly correlated with NO2
(r=0.8), moderately correlated with SO2 (r=0.5) and negatively
correlated with O3 (r=−0.4).Figure 1 Cohort and case identiﬁcation.
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Of the 812 063 cohort participants, 16 034 (1.92%) received
a COPD diagnosis on their GP record and 2910 (0.35%) were
admitted to hospital for COPD during the follow-up period
2003–2007 (ﬁgure 1). Of the 2910 patients admitted to hospital
with a diagnosis of COPD, 1860 (64%) received a diagnosis of
COPD on their GP record by the end of 2007. Extending the
exclusion criteria for GP diagnosed COPD to patients with
other previously recorded chronic respiratory diseases, such as
asthma, reduced the cohort to 694 189 patients, with 8893
(1.28%) patients subsequently receiving an incident diagnosis of
COPD.
Table 2 shows the incidence of GP and HES recorded COPD
stratiﬁed by sex, age, smoking status, BMI, practice region and
IMD. Incidence of GP diagnosed COPD was higher in men
than in women (2.2% vs 1.8%), but the sex ratio was similar for
hospital admissions. Incident cases of COPD increased with age,
with only a small reduction in the oldest group (80–89 years)
for GP diagnosed COPD. Increasing smoking intensity at base-
line, both current and historical, strongly predicted COPD inci-
dence. There was also a strong gradient with IMD, both for GP
and hospital recorded COPD, with increasing incidence of both
outcomes as deprivation increased. For example, using GP diag-
noses, patients in the most deprived decile had an incidence rate
almost four times higher than those in the least deprived decile
(4.18–1.13%), while for hospital admissions this ratio was
almost ﬁve (0.88% vs 0.18%). The pattern with IMD was
observed across all smoking categories (data not shown). The
strong associations with IMD were likely to account for some of
the regional variation in COPD incidence, with higher rates in
the north compared to the south. However, even among the
most deprived IMD decile, north-south differences were still
apparent (4.6% vs 3.4%).
The associations between an IQR change in assigned air pol-
lution concentration in 2002 and a 5-year incidence of COPD
recorded on the GP record and for admission to hospital are
quantiﬁed in a series of HRs in table 3. All pollutants except
ozone were positively associated with an increased risk for inci-
dent GP recorded COPD when adjusted for age and sex alone.
Adjustment for smoking and BMI attenuated all associations,
with further adjustment for IMD reducing nearly all associations
to the null. The main exception was for SO2 where a 2.2 mg/m
3
increment was associated with an HR=1.07 (95% CI: 1.03 to
1.11). Alternative adjustments for IMD based on individual
components (income, education and employment) produced
similar reductions in HRs (data not shown). Extending the
exclusion criteria to also exclude patients with other previously
recorded respiratory disease such as asthma strengthened asso-
ciations for PM10 and PM2.5; however, CIs still included unity.
In two-pollutant models, the SO2 association remained robust
to adjustment for other pollutants (see online supplementary
material table S3). Finally, alternative frailty models using a
random effect to account for practice clustering did not materi-
ally alter our conclusions (data not shown).
Analyses using incidence based on an admission to hospital
for COPD generally produced associations with air pollution
greater in magnitude than those seen with GP diagnosis alone
(table 3). Again, adjustment for covariates and IMD in particular
markedly reduced associations, with all 95% CIs including
unity. For example, IQR increments in PM2.5 (1.9 mg/m
3), SO2
(2.2 mg/m3) and NO2 (10.7 mg/m
3) were associated with HRs of
Table 1 Summary of assigned pollutant concentrations in 2002 for participants with no diagnosis of COPD by end of 2002 (n=812 063)
Assigned annual average concentration in 2002 (mg/m3)
PM10 PM2.5 SO2 NO2 O3
No. with pollution linkage (%) 807 401 (99) 807 401 (99) 800 360 (99) 807 000 (99) 801 380 (99)
Mean concentration (SD) 19.7 (2.3) 12.9 (1.4) 3.9 (2.1) 22.5 (7.4) 51.7 (2.4)
IQR 3.0 1.9 2.2 10.7 3.0
Practice region means (SD)
North [81 practices] 19.8 (2.3) 12.9 (1.5) 4.8 (2.1) 23.4 (6.3) 50.9 (2.4)
South (ex. London) [96 practices] 19.1 (2.0) 12.5 (1.2) 3.2 (1.9) 19.4 (6.1) 52.6 (2.2)
London [28 practices] 22.5 (1.2) 14.6 (0.8) 3.8 (1.2) 33.3 (4.5) 50.2 (0.8)
Test for heterogeneity p<0.001 p<0.001 p<0.001 p<0.001 p<0.001
Modified IMD quintile means (SD)
1 (Most deprived) 21.0 (2.2) 13.7 (1.5) 4.7 (2.2) 26.9 (6.3) 50.9 (2.1)
2 21.1 (2.6) 13.8 (1.7) 4.2 (2.3) 26.5 (7.9) 51.3 (2.2)
3 20.4 (2.6) 13.3 (1.7) 4.5 (2.5) 24.2 (8.1) 51.2 (2.2)
4 20.0 (2.3) 13.1 (1.5) 4.4 (2.5) 23.2 (7.5) 51.3 (2.2)
5 19.5 (2.6) 12.7 (1.6) 3.9 (2.4) 21.6 (8.2) 52.1 (2.6)
6 19.3 (2.4) 12.6 (1.5) 3.7 (1.9) 21.1 (7.6) 51.6 (2.6)
7 19.3 (2.3) 12.6 (1.4) 3.9 (2.1) 21.3 (7.5) 51.6 (2.6)
8 19.3 (2.0) 12.6 (1.3) 3.6 (1.8) 20.9 (6.7) 51.8 (2.4)
9 19.4 (1.9) 12.6 (1.2) 3.6 (1.7) 21.8 (6.6) 51.9 (2.3)
10 (Least deprived) 19.6 (1.5) 12.8 (0.9) 3.6 (1.3) 22.1 (5.6) 52.2 (1.9)
Test for trend p<0.001 p<0.001 p<0.001 p<0.001 p<0.001
Correlation* between pollutants
PM2.5 0.99 – – – –
SO2 0.45 0.46 – – –
NO2 0.84 0.85 0.38 – –
O3 −0.40 −0.39 −0.41 −0.47 –
*Spearman’s rank correlation coefficient.
COPD, chronic obstructive pulmonary disease; IMD, Index of Multiple Deprivation; IQR, interquartile range.
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1.05 (95% CI 0.98 to 1.13), 1.01 (95% CI 0.97 to 1.07) and
1.06 (95% CI 0.98 to 1.15), respectively. The HR for ozone
was 0.96 (95% CI 0.90 to 1.02). Restricting the analysis to
admissions in participants with COPD conﬁrmed by their GP
did not materially alter our ﬁndings.
We stratiﬁed the adjusted HRs in table 3 by IMD deciles (ﬁgure
2). For PM2.5 and NO2, there was no consistent evidence of a posi-
tive association across different deprivation groups using either GP
diagnoses or hospital admission as the outcome. For SO2, the asso-
ciation consistently produced an HR>1 for GP diagnoses, but was
less uniform for hospital admissions. The reverse was true for O3
where the HR was generally <1 across the IMD deciles.
Stratifying the analyses by other covariates such as age and
smoking did not reveal any other patterns (data not shown).
DISCUSSION
In this cohort study of general practice patients, we investigated
the relationship between estimates of long-term exposure to
outdoor air pollution and the incidence of COPD recorded by
GPs and by admission to hospital. While all pollutants except
ozone were positively associated with increased risk for incident
GP recorded COPD, adjustment for smoking, BMI and IMD in
particular reduced associations towards the null except for SO2.
Associations with COPD hospital admissions were larger and
remained positive for PM2.5, PM10 and NO2 and negative for
O3 after full adjustment, although all CIs included unity.
Sensitivity analyses based on excluding asthmatic patients from
the analysis, or only counting hospital admissions with a diagno-
sis conﬁrmed on the GP record, did not alter our ﬁndings
materially.
Early longitudinal studies of air pollution and the develop-
ment of COPD used respiratory symptoms to identify partici-
pants with COPD17 18 while others used lung function
measurements, such as forced expiratory volume in the ﬁrst
(FEV1)/forced vital capacity (FVC) ratio
19–21 or the GOLD cri-
terion.9 A very recent reanalysis and meta-analysis of four
European cohorts (in total 6550 participants and including a
UK cohort) used FEV1/FVC and the GOLD criterion to deﬁne
Table 2 Age–sex adjusted COPD incidence rates by baseline factors
Baseline variables Level
All eligible
patients COPD incidence (GP diagnosed)
COPD incidence (hospital
admission)
N n Age–sex adjusted (%) n Age–sex adjusted (%)
All – 812 063 16 034 1.92 2910 0.35
Sex Male 392 574 8382 2.18 1435 0.38
Female 419 489 7652 1.84 1475 0.36
Age (years) 40–49 241 580 1144 0.47 157 0.07
50–59 224 817 3472 1.55 400 0.18
60–69 159 628 4846 3.04 728 0.46
70–79 119 832 4728 3.95 965 0.81
80–89 66 206 1844 2.80 660 1.01
Smoking Non 381 579 2781 0.75 450 0.12
Ex (unknown) 72 646 1390 1.43 265 0.26
Ex (1–19 cigarettes/day) 50 670 1906 3.39 334 0.60
Ex (20–39 cigarettes/day) 23 896 1389 5.63 204 0.90
Ex (40+ cigarettes/day) 4616 330 6.32 48 0.82
Current (unknown) 17 048 268 1.28 60 0.26
Current (1–19 cigarettes/day) 84 386 3449 4.87 685 1.10
Current (20–39 cigarettes/day) 48 246 2572 7.07 471 1.69
Current (40+ cigarettes/day) 4246 361 9.20 63 1.73
Not recorded 124 730 1588 1.27 330 0.29
BMI (kg/m2) <20 31 134 935 4.04 232 0.99
≥20 and <25 262 208 5263 2.16 830 0.35
≥25 and <30 236 394 4715 1.85 783 0.31
≥30 105 469 2373 2.23 475 0.46
Not recorded 176 858 2748 1.72 590 0.36
Practice Region North 307 826 7270 2.39 1305 0.44
South (excluding London) 414 539 7259 1.76 1313 0.32
London 89 698 1505 1.86 292 0.37
IMD Decile 1 (most deprived) 44 037 1785 4.18 380 0.88
=2 53 439 1640 3.19 323 0.62
=3 67 133 1906 2.89 371 0.56
=4 74 147 1726 2.36 354 0.48
=5 79 579 1586 1.97 287 0.35
=6 87 057 1648 1.92 293 0.35
=7 92 102 1517 1.65 289 0.32
=8 111 891 1737 1.57 251 0.23
=9 94 877 1361 1.48 195 0.22
=10 (least deprived) 106 870 1113 1.13 167 0.18
BMI, body mass index; COPD, chronic obstructive pulmonary disease; GP, general practitioner; IMD, Index of Multiple Deprivation.
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COPD and found positive, but not statistically signiﬁcant, asso-
ciations with NO2 and PM10.
9 Epidemiological studies designed
to identify the small associations between air pollution and
health outcomes require disease recording in large populations,
which precludes the use of individual lung function measure-
ments. Only a small number of studies have used routine admin-
istrative databases such as hospital admissions records to
identify COPD cases. Andersen et al10 studied 57 000 partici-
pants in a Danish cohort recording their ﬁrst admission to
hospital for COPD between 1993 and 2006. COPD incidence
was associated with 35-year estimated residential mean NO2
concentrations (HR=1.08; 95% CI, 1.02 to 1.14, per IQR of
5.8 mg/m3)—an association larger for the same increment in our
study (HR=1.03). Gan et al11 also studied hospitalisations for
COPD in a cohort of almost 500 000 residents in metropolitan
Vancouver aged 45–85 years and without a previous physician
diagnosis of COPD at baseline. Residential exposures to NO2
estimated from land use regression models were not associated
Table 3 Hazard ratios for the incidence of COPD for an interquartile change in each pollutant
Adjustment factors
PM10 (n=807 401) PM2.5 (n=807 401) SO2 (n=800 360) NO2 (n=807 000) O3 (n=801 380)
HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI
Outcome=First diagnosis of COPD on GP record in 2003–2007, Exclusions=Any COPD recorded on GP record prior to 2003
Age and sex 1.10 1.02 to 1.19 1.12 1.04 to 1.21 1.14 1.09 to 1.19 1.17 1.08 to 1.26 0.88 0.82 to 0.94
+Smoking and BMI 1.06 0.99 to 1.13 1.07 1.00 to 1.15 1.11 1.07 to 1.16 1.11 1.03 to 1.20 0.91 0.85 to 0.97
+IMD 0.99 0.93 to 1.05 1.00 0.94 to 1.06 1.07 1.03 to 1.11 1.03 0.96 to 1.11 0.94 0.89 to 1.00
Full model (10 unit increase) 0.97 0.79 to 1.18 0.97 0.71 to 1.34 1.36 1.14 to 1.62 1.03 0.96 to 1.10 0.82 0.67 to 0.99
Outcome=First diagnosis of COPD on GP record in 2003–2007, Exclusions=Any Markers of Respiratory Disease prior to 2003*
+IMD 1.01 0.94 to 1.09 1.02 0.94 to 1.09 1.08 1.03 to 1.13 1.04 0.96 to 1.13 0.94 0.87 to 1.00
Outcome=First Hospital Admission for COPD in 2003–2007, Exclusions=Any COPD recorded on GP record prior to 2003
Age and sex 1.21 1.11 to 1.32 1.23 1.13 to 1.34 1.11 1.05 to 1.17 1.25 1.14 to 1.36 0.87 0.80 to 0.95
+Smoking and BMI 1.15 1.06 to 1.24 1.16 1.08 to 1.26 1.08 1.02 to 1.13 1.17 1.08 to 1.28 0.90 0.84 to 0.97
+IMD 1.05 0.98 to 1.12 1.05 0.98 to 1.13 1.01 0.97 to 1.07 1.06 0.98 to 1.15 0.96 0.90 to 1.02
Full model (10 unit increase) 1.17 0.93 to 1.46 1.31 0.92 to 1.86 1.07 0.86 to 1.33 1.06 0.98 to 1.14 0.87 0.69 to 1.08
Outcome=First Hospital Admission for COPD in 2003–2007 with additional GP diagnosis, Exclusions=Any COPD recorded on GP record prior to 2003
+IMD 1.05 0.96 to 1.14 1.05 0.97 to 1.14 1.04 0.98 to 1.10 1.04 0.94 to 1.15 0.97 0.90 to 1.05
Hazard ratios are for IQR change in pollutant level unless stated (PM10=3.0 mg/m
3, PM2.5=1.9 mg/m
3, SO2=2.2 mg/m
3, NO2=10.7 mg/m
3, O3=3.0 mg/m
3). Practice is accounted for in
the above models by the sandwich estimator to produce robust standard errors.
*The numbers of patients in the analyses with this additional exclusion were: PM10/PM2.5 n=690 102, SO2 n=684 261, NO2 n=689 767, O3 n=684 261.
BMI, body mass index; COPD, chronic obstructive pulmonary disease; GP, general practitioner; HES, hospital episode statistics; IMD, Index of Multiple Deprivation.
Figure 2 Hazard ratios and 95% conﬁdence intervals for the incidence of Chronic Obstructive Pulmonary Disease for an interquartile change in
each pollutant stratiﬁed by Index of Multiple Deprivation deciles.
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with COPD hospitalisations (HR=1.00). They also found no
evidence of an association with PM2.5 (HR=1.02 (95% CI 0.98
to 1.06) per 1.58 mg/m3 increment, which compares to
HR=1.04 for the same increment in our study.
Our ﬁnding of an association between long-term exposure to
SO2 and COPD is, to the best of our knowledge, new, although
we note that this ﬁnding is speciﬁc to GP recorded COPD and
hospital admission when conﬁrmed by the GP. SO2 has been
associated with respiratory mortality in some, but not all,
cohort studies.5 Short-term exposure time-series studies have
indicated associations between daily concentrations of SO2 and
emergency hospital admissions for COPD22 but not GP consul-
tations for lower respiratory disease excluding asthma.23 Given
the lack of a plausible hypothesis linking current low levels of
SO2 to health,
24 it is possible that our ﬁnding reﬂects historical
exposure to higher concentrations of SO2, or that our SO2
model, which showed an association with cardiovascular disease
in a previous analysis,15 is providing a geographical proxy of
poor overall health or acts as a marker for more toxic substances
produced by the combustion of sulfur-containing fossil fuel.
We also found that associations with ozone were consistently
negative, which we have seen previously with cardiovascular
disease and mortality.5 15 While this is in part explained by nega-
tive correlations between ozone and the other pollutants, the
smaller variation of ozone concentration by area probably results
in it better representing regional levels. An analysis conﬁned to
the months in which ozone levels are highest might have been
informative, but we were unable to stratify by season.2
In our study, we used two distinct data sources to identify
COPD over time—GP diagnoses and hospital admissions. The
use of a nationally representative UK primary care database to
study COPD incidence has been established,25 but some import-
ant changes that might affect recording have taken place. One
of the most notable changes was the introduction of the Quality
and Outcomes Framework in 2004 which required GPs to
conﬁrm their COPD diagnoses by spirometry from 2006
onwards. This change may have temporarily introduced add-
itional variability in the recording of diagnoses across practices.
However, the introduction of spirometry should improve diag-
nostic certainty and lead to improved and more speciﬁc
outcome measures for use in epidemiological studies of air pol-
lution where large sample sizes are required to detect relatively
small effects.
We also used hospital admissions for COPD as an outcome.
Andersen et al10 noted the appeal of using an objective measure
such as ﬁrst-ever hospital admission assessed objectively from a
nationwide register but recognised that such patients repre-
sented only those with severe or poorly controlled COPD.
Hence, admissions are unlikely to represent the real burden of
COPD in the population.10 In this respect, our study had the
beneﬁt of two large, quality assured, independent sources of
data to identify incidence: hospital admissions records to iden-
tify participants at the severe end of the spectrum of disease and
primary care records incorporating participants with COPD
who had not yet required admission to hospital. However, the
consistency in recording of a COPD diagnosis between the two
was not complete—36% of incident hospital admissions for
COPD were not conﬁrmed by a corresponding GP diagnosis
during the study. A sensitivity analysis restricting hospital admis-
sions to those corroborated by a subsequent GP diagnosis of
COPD did not alter substantively the associations observed with
hospital admissions. While the use of large-scale databases
allows us to detect small effects in large populations, the lack of
consistency between the two outcomes limits the conclusions
that can be drawn from each analysis.
We found that adjustment for deprivation had a substantial
effect on all HRs, moving all associations towards unity and stat-
istical non-signiﬁcance. The direction of this adjustment is not
surprising as lower SES has been shown to be related to poorer
air quality and respiratory function in England previously.26
Adjustment for deprivation is important as it is associated with
air pollution as well as other factors that might be correlated
with COPD outcomes.27 We were limited by relying on census
measures of deprivation based on a geographical area of
approximately 1500 people;13 however, neighbourhood SES
indicators can be an acceptable proxy for individual measures.28
It is possible that in urban areas the IMD may represent
ﬁne-scale variability in actual pollution levels not represented by
our modelled estimates. For example, within the modelled
1×1 km area, patients living closer to busy roads are assigned
identical exposure as those further away, but may have different
deprivation proﬁles.29 While this may raise the possibility that
we have overadjusted in our models, when we stratiﬁed our ana-
lysis by IMD deciles, we found little evidence of consistent
effects of air pollution within the separate groups and no evi-
dence of greater effects in areas of low socioeconomic character-
istics.30 It is also possible that some of the IMD adjustment may
be acting as a proxy for further smoking history, as our smoking
variable was unable to calculate lifetime pack years.
We have discussed previously the performance and validation
(see online supplementary material) of our air pollution disper-
sion models.5 We note that the validity of the modelled expos-
ure data (as measured by R2 statistics in relation to monitored
data) varied among the pollutants and from year to year. In
2002, our chosen year for exposure assignment, model valid-
ation was good for NO2, moderate for PM10 and poor for SO2,
although this varied substantially from year to year (R2=0.23–
0.45 at national network sites and 0–0.6 at the veriﬁcation
sites). Models for ozone demonstrated good to reasonable
model performance. The difﬁculty in modelling PM and SO2
has been well documented31 32 and we note also that alternative
pollution models have reported similar performance when
applied to the UK.31 32 Other sensitivity analysis using exposure
estimates averaged over a number of years, which include better
validation statistics, largely conﬁrmed our ﬁndings based on the
2002 data only including associations with SO2 (data not
shown). Nonetheless, we believe that the poorer model per-
formance for PM10 and SO2 relative to NO2 should be taken
into consideration in the overall assessment of our results.
In comparison with other cohort studies of COPD, our pollu-
tion estimates differed in terms of spatial resolution (1×1 km
grids vs residential,10 postcode11) and historical exposure (3510
and 5 years11). The question of historical versus recent exposure
has been considered previously33 in relation to mortality in the
American Cancer Society cohort3 and no strong evidence was
found to support earlier over more recent pollution exposure
estimates. Annual estimates of pollution concentrations from
our model for other years around 2002 suggested strong corre-
lations over time, so a single exposure year provides an accept-
able proxy of longer exposure over time. However, we note that
our estimates of pollution exposure may not adequately repre-
sent cumulative exposure over prior decades, especially where
concentrations have generally been falling over time. A further
limitation of our study was the relatively short follow-up period
(up to 5 years), although this was mitigated to some extent by
the size of the study population and number of events (>16 000
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and >2900 incident COPD cases recorded by a GP and admis-
sion, respectively).
In a previous analysis of the same cohort,5 we found associa-
tions with COPD and respiratory mortality, which were compar-
able with those for hospitalisations reported in this case;
however, owing to the relatively smaller number of mortality
outcomes (less than 30%), the precision of our estimates was
reduced. Hospital admissions may not represent a true incident
point but may instead indicate the role of air pollution in
exacerbating COPD. This hypothesis is supported by evidence
from short-term exposure time-series studies which have found
positive associations between daily concentrations of air pollu-
tion to increase in numbers of COPD hospital admissions and
mortality in urban populations.22 34 35
In conclusion, this large population-based cohort study found
only limited, inconclusive evidence for associations between air
pollution concentrations and COPD incidence and inconsistency
between results for COPD identiﬁed from GP records and from
hospital admissions. Given the ubiquitous nature of the expos-
ure and the substantial social and economic burden of the
disease, further work utilising improved estimates of air pollu-
tion exposure for cohort participants, individual markers of
SES, longer follow-up times and a more precise disease deﬁn-
ition is required to clarify the role of air pollution in the initi-
ation of COPD.
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